Drug intelligence / Profile preview

Cheezhou

Development stage
Unknown
Lead developer
Yinyi
Modality
Small Molecules, Device-based Delivery → Drug Delivery Systems
01

Overview

"Cheezhou" refers to a drug-eluting balloon catheter system, specifically the Cheezhou® (Bingo) Coronary Drug-Eluting Balloon Catheter. This medical device delivers the antiproliferative drug paclitaxel to the vessel wall during angioplasty. Paclitaxel interferes with microtubule function, inhibiting vascular smooth muscle cell proliferation and intimal hyperplasia, thereby preventing restenosis. The balloon also utilizes iodixanol as an excipient to enhance drug stability and bioavailability. Developed and manufactured by Liaoning Yinyi Biological Technology Co., Ltd., the Cheezhou drug-eluting balloon is indicated for the treatment of coronary artery disease, particularly for dilation of stenosis in primary bifurcation coronary artery lesions. It was the first drug-eluting balloon catheter approved in China for coronary bifurcation lesions.

Brand names
轻舟Bingo
Other names
轻舟药物洗脱球囊导管Cheezhou drug elution balloon catheter
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on Cheezhou.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cheezhou.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call